Comment on “Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma”

Lignende værker

• Response to the comment on “Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma” by Bielamowicz et al
  af: Joseph, Sujith K, et al.
  Udgivet: (2018)
• Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
  af: Bielamowicz, Kevin, et al.
  Udgivet: (2018)
• Steering CAR T cells to distinguish friend from foe
  af: Caruso, Hillary G., et al.
  Udgivet: (2018)
• IMMU-17. REDUCING THE EX VIVO MANUFACTURING TIME OF EGFRVIII-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS IMPROVES PHENOTYPE AND DEMONSTRATES POTENT ANTI-GLIOMA FUNCTION IN VIVO
  af: Tanaka, Ryuma, et al.
  Udgivet: (2017)
• Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
  af: Martínez Bedoya, Darel, et al.
  Udgivet: (2021)